GHRS
GH Research PLC
NASDAQ: GHRS · HEALTHCARE · BIOTECHNOLOGY
$21.11
+3.23% today
Updated 2026-10-09
Market cap
$1.45B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.99
Dividend yield
—
52W range
$12 – $31
Volume
0.3M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C8.5
Quality
A3.0
Profitability
D5.0
Valuation
C+3/9
Piotroski F-Score
Weak
19.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →274 stocks currently score above 75
Price targets
Analyst target
$42.89
+103.17%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy7 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 19.54 — safe zone
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-15.04M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-22.46M | $-35.59M | $-38.96M | $-48.26M | $-15.15M |
| EPS | — | — | — | — | $-0.99 |
| Free cash flow | $-26.27M | $-33.44M | $-42.33M | $-43.67M | $-15.04M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
GH Research PLC trades at $21.11. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 19.54, it sits in the safe zone.
Frequently asked questions
What is GH Research PLC's stock price?
GH Research PLC (GHRS) trades at $21.11.
Is GH Research PLC overvalued?
GH Research PLC carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of GH Research PLC (GHRS)?
The 12-month analyst consensus target is $42.89, about 103.2% above the current $21.11. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
GH Research PLC's Altman Z-Score is 19.54, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-21.42%
Beta1.33
50D MA$27.21
200D MA$21.14
Shares out0.07B
Float0.03B
Short ratio—
Avg volume0.3M
Performance
1 week+11.31%
1 month+9.30%
3 months+3.16%
YTD+28.66%
1 year—
3 years—
5 years—